Mobileye Global Inc (MBLY)
NASDAQConsumer DiscretionaryAuto - PartsSnapshot 2026-09-14
$8.16-1.09%
Close 2026-09-14 · 1-day change
NASDAQConsumer DiscretionaryAuto - PartsSnapshot 2026-09-14
Research Workspace
Put MBLY beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Automotive Parts & Equipment: fringe margins under pressure (0q confirmed)
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue is growing steadily — about 5% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens weak on capital allocation, margins, the balance sheet.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 58% in its worst 12-month stretch.
View RiskMobileye's growth in advanced driver-assistance systems (ADAS) must continue to justify its price. Recent revenue growth shows promise, with a beat in Q2 FY2026. The stock trades at 24× P/E, which is 1.8× the peer median of 13×. This suggests the price reflects less growth than expected. If guidance is cut after a recent raise, it could hurt credibility. The read shows peer multiples imply a price roughly in line with where it trades. Our read remains intact.
Trailing returns as of 2026-09-14. MBLY is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 28 analysts currently covering MBLY (as of Sep 2026).
Based on 7 Wall Street analysts offering 12-month price targets for MBLY in the last 4 months.
Continue this research
Compare MBLY with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| MBLY Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 6 valuation methods, at three horizons. As of 2026-09-14. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Automotive Parts & Equipment — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put MBLY next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Advance humanoid robotics business
Advances humanoid robotics business through regulatory progress.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-14. EPS is implied from price ÷ P/E. Not investment advice.
Current $8.16
The last 12 months of price, then the range of analyst 12-month targets from today’s $8.16.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Improve adjusted operating income outlook
Upgrade suggests improved operating income outlook.
Advances: Increase revenue guidance for 2026
Increased price target supports revenue growth expectations.
Advances: Advance humanoid robotics business
Upgrade supports growth in humanoid robotics business.
CEO change may impact strategic direction and execution.
Advances: Improve adjusted operating income outlook
Strong profit growth supports improved operating income outlook.
Competition concerns could hinder revenue growth potential.
Threatens: Increase revenue guidance for 2026
Q2 results contradict revenue guidance expectations.